课题基金 / 基金详情

Insulin-like growth factor binding protein-3 (IGFBP-3) sensitivity and signalling in breast cancer

Insulin-like growth factor binding protein-3 (IGFBP-3) sensitivity and signalling in breast cancer
乳腺癌中胰岛素样生长因子结合蛋白 3 (IGFBP-3) 的敏感性和信号传导
批准号:
nhmrc : 107244
负责人:
Dr Janet Martin
金额:
$27.63万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2000
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2000-01-01 至 2002-12-31

项目摘要

项目成果

Dr Janet Martin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The growth of all tissues in the body depends on many growth factors, hormones and other proteins which work together to control cell division. Some of these factors stimulate the division of the cells which make up the body tissues, and some inhibit it, so that a balance of these stimulators and inhibitors ensures that tissues do not grow too fast, or too large. The development of breast cancer and the growth of breast tumours is thought to be due to uncontrolled or faulty actions of the proteins and hormones which regulate the way breast cells multiply. One protein which normally regulates the division of breast cells is IGFBP-3. We have found that in some breast cancer cells, IGFBP-3 is no longer able to inhibit cell division, and this may lead to tumour growth and invasion of other tissues. We are interested in finding out how IGFBP-3 normally controls breast cell proliferation, and why some breast cancers are resistant to IGFBP-3. To do this, we will use normal breast cells in culture to examine how IGFBP-3 interacts with other cellular factors to prevent cell division. We will then look at whether the breast cancer cells have changed so that they are no longer able to recognise IGFBP-3 as an inhibitory protein. This may be because of changes in the way IGFBP-3 binds to the breast cancer cell, or because of changes in the way it interacts with other proteins in the cell. Because IGFBP-3 is made by normal and breast cancer cells, we will also study whether the IGFBP-3 being made by breast cancer cells is normal, or if it changed in some way that makes it inactive. By understanding why some breast cancers are not inhibited by IGFBP-3, we will be able to design new and better methods of preventing, detecting and treating the growth of all breast tumours.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Endocrine and autocrine regulation of breast cancer cell growth by IGF binding protein-3 (IGFBP-3).
  • 批准号:
    nhmrc : 302153
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $33.16万
  • 财政年份:
    2004
  • 负责人:
    Dr Janet Martin
  • 依托单位:
国内基金
海外基金
BCL3介导前列腺癌Lum stem-like细胞干性维持与内分泌治疗抵抗的机制研究
  • 批准号:
    2026JJ70013
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    汤谷雨
  • 依托单位:
CDC like kinase 2调控巨噬细胞极化影响脓毒症肝损伤
  • 批准号:
    2026JJ81104
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    王剑
  • 依托单位:
桂花类胡萝卜素代谢相关新基因OfMYB-like的功能与机制解析
  • 批准号:
    JCZRYB202501133
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
HmWER-like调控花青素影响绣球‘无尽夏’蓝色萼片形成的机制研究
  • 批准号:
    2025JJ50137
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    彭继庆
  • 依托单位: